Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (ListingObligations and Disclosure Requirements) Regulations, 2015 read with Regulation 173A ofthe Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements)Regulations, 2018, enclosed herewith is the Monitoring Agency Report for the secondquarter ended September 30, 2025 issued by CARE Ratings Limited, Monitoring Agency forthe utilisation of the proceeds raised through Qualified Institutions Placement.
GENESYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genesys International has submitted the Monitoring Agency Report for the second quarter ended September 30, 2025, as required under SEBI's Listing Obligations and Disclosure Requirements Regulations. The report was issued by CARE Ratings Limited, which serves as the Monitoring Agency for tracking how the company is using the funds raised through its earlier Qualified Institutions Placement (QIP). This is a routine regulatory compliance filing confirming that an independent agency is overseeing the deployment of QIP proceeds. No specific utilization details, deviations, or concerns are disclosed in the headline.
This is a procedural compliance filing rather than a material business update, so it is unlikely to move the stock price. However, investors should review the actual Monitoring Agency Report for any deviations from the stated purpose of QIP fundraising, as misuse of proceeds could be a red flag.